Vessel Occlusion for Uterine Fibroids
(Myo-Bleed Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This study hypothesizes that temporary bilateral uterine and utero-ovarian artery occlusion with laparoscopic clamps at time of minimally invasive myomectomy will lead to a decreased blood loss at time of myomectomy compared to minimally invasive myomectomy without temporary occlusion.
Are You a Good Fit for This Trial?
This trial is for people having minimally invasive surgery to remove uterine fibroids, either a single large fibroid (5 cm or bigger) or at least five fibroids. Participants must be eligible for this type of surgery.Inclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Temporary clamping of uterine and ovarian vessels
Trial Overview
The study compares two surgical methods: one uses temporary clamps to block blood flow in the uterine and ovarian vessels during myomectomy, while the other does not use these clamps. The goal is to see if clamping reduces blood loss.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Use of temporary laparoscopic vessel clamps on uterine and ovarian vessels
No use of vessel clamps
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.